Jan 12, 2023 / 12:30AM GMT
Ethan Taylor -
Good afternoon, everyone, and welcome to the Harmony Biosciences Company Presentation. My name is Ethan Taylor. I'm the associate in JPMorgan's Healthcare Investment Banking Group. It is my pleasure to introduce Jeffrey Dayno, Interim CEO and Chief Medical Officer. Upon conclusion of Jeffrey's presentation, we will hold a brief Q&A session to discuss topics that are top of mind among investors.
So with that, Jeff, please take it away.
Jeffrey M. Dayno - Harmony Biosciences Holdings, Inc. - Interim CEO, Executive VP & Chief Medical Officer
Thank you, Ethan, for the kind introduction. And I also want to thank JPMorgan for the opportunity to have Harmony share a bit of their story at the conference this year.
Good afternoon, everyone, and thank you for attending this session, especially late on a Wednesday afternoon at JPM to hear a little bit about Harmony Biosciences. So as a reminder, I'll be making forward-looking statements today. Please refer to Harmony's SEC filings and our corporate website for more details.
So
Harmony Biosciences Holdings Inc at JPMorgan Healthcare Conference Transcript
Jan 12, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers